Navigation Links
Pearl Therapeutics' Bronchodilator Combination PT003 Provides Superior Inspiratory Capacity Compared to Spiriva®
Date:9/26/2011

to optimize the treatment of COPD.

About Pearl Therapeutics

Pearl Therapeutics is a privately held company developing combination therapies for the treatment of highly prevalent respiratory diseases, including chronic obstructive pulmonary disease and asthma. Pearl is rapidly advancing a pipeline of products including PT003, an inhaled, fixed-dose combination bronchodilator product comprised of a long-acting muscarinic antagonist (LAMA) and a long-acting beta-2 agonist (LABA) delivered via a metered dose inhaler (HFA MDI); and PT010, a triple-combination product that combines the LAMA and LABA components of PT003 with an inhaled corticosteroid (ICS) for twice-daily administration from an HFA MDI for the treatment of severe COPD. Both PT003 and PT001 are developed with Pearl's proprietary porous particle cosuspension technology, which allows the formulation of multiple products in the MDI format, with highly stable, robust and aerodynamically efficient drug delivery. Founded in 2006, Pearl Therapeutics is privately held and backed by 5AM Ventures, Clarus Ventures, New Leaf Ventures and Vatera Healthcare. For more information, please visit www.pearltherapeutics.com.

* FEV1 (forced expiratory volumes in one second) is a common measurement of lung function in patients with asthma, cystic fibrosis, and COPD and is typically used to predict the severity of pulmonary disease. AUC (area under the curve) is a measure of therapeutic benefit over a period of time.

Editor's note: Spiriva® HandiHaler® (tiotropium bromide inhalation powder) is a registered trademark of Boehringer Ingelheim Pharmaceuticals; Foradil® is a registered trademark of Astellas Pharma; and Aerolizer® is a registered trademark of Novartis AG.


'/>"/>
SOURCE Pearl Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pearl Therapeutics Announces Positive Results for Phase 2b Dose-Ranging Study of Formoterol MDI
2. Pearl Therapeutics Advances Its Long-Acting Bronchodilator Combination Product Candidate into Four Additional Phase 2 Studies
3. Pearl Therapeutics Phase 2b Results Show a 50% Improvement in Lung Function with PT003 Compared to Spiriva® and Foradil® in Patients with COPD
4. Asante Solutions Receives FDA Clearance for Pearl™ Insulin Pump
5. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
6. Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting
7. Asante Solutions, Inc. Receives CE Mark for Pearl™ Insulin Pump
8. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
9. Afraxis Enters Collaboration with NIH as Part of Therapeutics for Rare and Neglected Disease Program
10. Reed V. Tuckson, M.D., Executive Vice President and Chief of Medical Affairs at UnitedHealth Group, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
11. Prime Therapeutics Launches CareCentered Contracting™ Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)...  Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), ... 3D bioprinting technology, announced today that Keith ... present live at VirtualInvestorConferences.com on March 5th. ... for this Company update," said Mr. Murphy. "We ... of the exVive3D Liver, Bioprinted Human Tissue, commercialization ...
(Date:2/27/2015)... YORK , Feb. 27, 2015 /PRNewswire/ ... are increasing in applications as their effectiveness ... firm Kalorama Information.  Kalorama Information says that ... is the most powerful tool in proteomic ... spec; MS) through its traditional techniques has ...
(Date:2/26/2015)... , Feb. 26, 2015  Today the National ... The psychological and physical side effects of pain medications ... painkillers, such as Vicodin and Oxycontin, are safer options ... overdose on prescription painkillers than on heroin and cocaine ... CEO of NSC. "Yet, these medications are marketed as ...
Breaking Medicine Technology:Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2
... Eli Lilly and Company (NYSE: LLY ) will announce its ... 2010 .  Lilly will also conduct a conference call on that day with ... , , , ... from 9:00 a.m. to 10:00 a.m. EDT .  Investors, media and the ...
... RALEIGH, N.C. , July 9 Pioneer Surgical Technology, ... technical biologic expertise to support their growing line of products that address ... , , ... stated, "We are extremely pleased with our ability to provide innovative biologic ...
Cached Medicine Technology:Lilly Confirms Date and Conference Call for Second-Quarter 2010 Financial Results Announcement 2Pioneer® Surgical Expands Product Specialists to Support Growing Biologics Business 2
(Date:2/28/2015)... 2015 The Mesothelioma Applied Research ... at the International Symposium on Malignant Mesothelioma on Monday, ... the Hyatt Regency Bethesda in Bethesda, Maryland. The following ... and commitment to the mission to cure mesothelioma. , ... be presented to Miriam Ratner. Miriam runs the Meso ...
(Date:2/28/2015)... Beach, CA (PRWEB) February 28, 2015 ... needs of Central Coast area residents, recently announced a ... System. It’s a treatment option for new and ... kick off 2015 with a bright, white smile, Dr. ... discounted price of $299, marked down from the regular ...
(Date:2/28/2015)... Kaylie Corrigan, Outdoor Supervisor at Back2Basics ... current student obtaining her Masters degree in social work ... in psychoeducation on substance use for teens at the ... of her studies. , “Even though these students are ... at the high school and junior high school level,” ...
(Date:2/28/2015)... February 28, 2015 The noted Friedman ... that they have officially relaunched their website. The new ... but it contains a new section about their team ... read the full biographies of each Friedman Dental Group ... the website was designed to provide our patients with ...
(Date:2/28/2015)... Janesville, WI (PRWEB) February 28, 2015 ... The designation recognizes Mercy Harvard Hospital as stroke capable ... to be brought via ambulance to Mercy Harvard Hospital. ... the state to indicate their ability to treat stroke ... The designation allows ambulances transporting stroke patients to bypass ...
Breaking Medicine News(10 mins):Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2
... of East Anglia,s Climatic Research Unit (CRU) are leaked on the ... calls for a debate into science and transparency. , Emails were ... ,Information Gap, leading science writer Fred Pearce argues that ,if CRU ... great deal of time and angst on the part of its ...
... Cambridge, Mass. November 30, 2011 From targeted ... the 21st century may prove to be the age ... though, will be miniscule. Experts in chemistry, applied ... week for the BASF Advanced Research Initiative at Harvard ...
... creatures on Earth have skin that produces the greatest ... becoming new weapons in the battle against antibiotic-resistant infections, ... (like rotten fish, for instance) that scientists term them ... Research . Yun Zhang, Wen-Hui Lee and Xinwang ...
... -- There may be a link between high blood sugar ... women, a new study finds. Researchers analyzed 12 years ... Women,s Health Initiative study. The women,s fasting blood sugar (glucose) ... study and then several more times over the next dozen ...
... have a financial interest in imaging equipment are more ... exams, according to a study presented today at the ... (RSNA). "Self-referral," whereby a non-radiologist physician orders ... which that physician has a financial interest, is a ...
... HealthDay Reporter , TUESDAY, Nov. 29 (HealthDay News) ... In a 12-month study of 123 overweight or obese women, ... than those who skipped a mid-morning nosh. The finding ... the short interval between breakfast and lunch for these snackers, ...
Cached Medicine News:Health News:Is transparency bad for science? 2Health News:Nano meets pharma at Harvard-BASF symposium 2Health News:Nano meets pharma at Harvard-BASF symposium 3Health News:Women's High Blood Sugar Linked to Colorectal Cancer: Study 2Health News:Self-referral leads to more negative exams for patients 2Health News:Mid-Morning Snacks May Thwart Diets 2Health News:Mid-Morning Snacks May Thwart Diets 3
... Deluxe specimen bath mounts inside the existing black ... for the separation of buffer and ice kept ... can be sterilized and has round mounting disks ... The disks and bath surface are marked ...
Punch set for Advanced Tissue Arrayer, 1.5 mm...
Inquire...
Inquire...
Medicine Products: